Medical News

RSS

National Pasteurized Eggs opens new state-of-the-art egg pasteurizing plant

In tandem with the Food and Drug Administration's quest to dramatically reduce Salmonella-related food poisoning, National Pasteurized Eggs (NPE) www.SafeEggs.com, the country's largest shell egg pasteurizer, opened a new state-of-the-art plant that more than doubles its production and expands Americans' access to eggs free from dangerous egg-related Salmonella-enteritidis.

3 Sep 2009

Medquist enters into revolving credit facility for meeting working capital expenses

MedQuist Inc. (Nasdaq: MEDQ) today announced it has entered into a five-year $25 million revolving credit facility. The credit facility provides committed revolving funding through August 2014 and includes an option whereby the Company may increase its maximum credit up to $40 million, based on certain terms and conditions.

3 Sep 2009

Iowa voters are less confident in the safety of food sold in the U.S.

Ninety percent of voting Iowans believe the government should be given additional authority to ensure the food they eat does not make them sick, according to a new poll commissioned by The Pew Charitable Trusts and conducted by Hart Research and Public Opinion Strategies.

3 Sep 2009

SAFLUTAN launched in United Kingdom and Spain

Merck Sharp & Dohme (MSD) has launched SAFLUTAN (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today.

3 Sep 2009

Atlantic Health uses SuccessFactors Performance and Talent Management Suite

SuccessFactors, Inc., the global leader in on-demand performance and talent management solutions, announced today that Atlantic Health, which was recently named by FORTUNE as one of the "100 Best Companies To Work For," is using SuccessFactors Performance and Talent Management Suite to help improve overall business performance by aligning employee performance goals with overall company goals, and streamline its talent management processes.

3 Sep 2009

UK Performance Network signs agreements with South West and thirteen PCTs

The UK Performance Network announced it has signed agreements with the South West Strategic Health Authority and thirteen primary care trusts (PCTs) in the South West as new subscribers.

3 Sep 2009

SIMH's CEO announces the launch of Sanomedics Development Corporation

Keith Houlihan, president and Chief Executive Officer of Sanomedics International Holdings Inc., today announced the launch of Sanomedics Development Corporation, to be led by Abhishek Shrivastava, Chief Technology Officer.

3 Sep 2009

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.

3 Sep 2009

Medtronic's COPE-HCV clinical study commences

Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company’s first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).

3 Sep 2009

Atrium Innovations supports Wobenzym(R) brand development in Germany

Atrium Innovations Inc. (TSX: ATB), a leading developer, manufacturer and marketer of science-based and professionally supported products for the Health and Nutrition industry, today announced various initiatives to support the development of its Wobenzym(R) brand in Germany.

3 Sep 2009

First edition: September 3, 2009

In today's headlines, President Obama announces that he will address a joint session of Congress next week in an effort to regain control of the health care reform debate.

3 Sep 2009

Sheller, P.C helps to settle the largest whistleblower complaint

Pfizer Inc. ignored a 2005 FDA Warning Letter to stop promoting its antibiotic Zyvox(R) as clinically superior to the significantly less expensive, generic vancomycin when its own FDA-approved label indicated otherwise. The drug giant also defrauded federal and state taxpayers by marketing Zyvox off-label, according to a qui tam whistleblower complaint filed by Philadelphia law firm Sheller, P.C. and other documents unsealed with today's $2.3 billion Pfizer settlement.

3 Sep 2009

Maldonado Medical collaborates with ANMM for facilitating claims reimbursement

Maldonado Medical LLC, a Durable Medical Equipment (DME) provider servicing the southwestern United States, has formed a strategic alliance with American National Medical Management (ANMM), a patients' claims management group that specializes in getting claims compensated in a timely manner with a proprietary process that enforces the legal terms of a patients health insurance policy.

3 Sep 2009

Low HDL-cholesterol and high triglycerides linked to increased risk of CHD

Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.

3 Sep 2009

Ten of ChemBridge's screening libraries available through CDD database

ChemBridge Corporation, a leading discovery chemistry company offering an extensive portfolio of discovery chemistry products and contract research services, has now made ten of their most popular screening libraries available to researchers via the Collaborative Drug Discovery (CDD) Public Access database.

3 Sep 2009

Celgene to collaborate with PTC on advancing drug discovery efforts

PTC Therapeutics, Inc. (PTC) today announced that Celgene Corporation has exercised its option to collaborate on advancing drug discovery efforts on an oncology target addressed through the application of PTC's GEMS(TM) (Gene Expression Modulation by Small-molecules) technology.

3 Sep 2009

Pfizer finalizes settlement agreement with U.S. DOJ regarding past promotional practices

Pfizer Inc today announced that it has finalized a previously reported agreement in principle with the U.S. Department of Justice (DOJ) to settle an investigation regarding past off-label promotional practices related to Bextra, which Pfizer voluntarily withdrew from the market in 2005.

3 Sep 2009

Uroplasty highlights the result of OrBIT trial of its Urgent PC System

Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.

3 Sep 2009

Damprid's recommendations for tackling seasonal allergy

For America’s 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.

3 Sep 2009

SuperGen to present at two upcoming investment conferences

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at two upcoming investment conferences.

3 Sep 2009